Obesity clinical trials in Georgia
47 studies for Obesity are looking for participants at sites in Georgia.
Cities in Georgia
- Atlanta27 studies
- Johns Creek16 studies
- Roswell13 studies
- South Fulton12 studies
- Sandy Springs6 studies
- Savannah4 studies
- Columbus4 studies
- Gainesville4 studies
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Conquest Research, Atlanta
- Eastside Bariatric and Gen Surg, Snellville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07668414AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Hope Clin Res & Wellness, Conyers
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07720271A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Stockbridge
- Research Site, Woodstock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07776509AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Hope Clin Res & Wellness, Conyers
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07339423A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Teak Research Consults - Dunwoody, Dunwoody
- Teak Research Consults, Lawrenceville
- Clinical Research Atlanta, Stockbridge
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- East Coast Institute for Research LLC at Canton Georgia, Canton
- The Jones Center Clinical Research, Macon
- Velocity Clinical Research - Savannah, Savannah
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Woodstock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Teak Research Consults - Dunwoody, Dunwoody
- Teak Research Consults, Lawrenceville
- The Jones Center Clinical Research, Macon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- North Georgia Clinical Research, Woodstock
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Teak Research Consults, Lawrenceville
- EBGS Clinical Research Center, Snellville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07369011A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Teak Research Consults - Dunwoody, Dunwoody
- Center for Advanced Research & Education, Gainesville
- Clinical Research Atlanta, Stockbridge
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Orita Clinical Research, Decatur
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07353931A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- Care Access - Decatur, Decatur
- North Georgia Clinical Research, Woodstock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07153471A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Canton
- AURORA-2 Clinical Site, Decatur
- AURORA-2 Clinical Site, Union City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Canton
- AURORA-1 Clinical Site, Decatur
- AURORA-1 Clinical Site, Union City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Piedmont Heart Institute, Atlanta
- Privia Medical Group Georgia LLC, Peachtree City
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351045A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville
- Physicians Research Associates, Lawrenceville
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centricity Research Columbus Georgia Multispecialty, Columbus
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
- Research Site, Decatur
RecruitingPhase 1/2Healthy volunteers welcome
Ages 25 to 75 · All sexes · Updated Sep 14, 2026 · NCT07815678AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Conquest Research, Atlanta
- Physicians Research Associates, Lawrenceville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07571005A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Atlanta
- ACCOMPLISH-2 Research Site, Columbus
- ACCOMPLISH-2 Research Site, Lawrenceville
- and 2 more
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Sep 11, 2026 · NCT07654374Intermittent Cottonseed Oil Consumption
- University of Georgia, Athens
RecruitingHealthy volunteers welcome
Ages 25 to 75 · All sexes · Updated Sep 9, 2026 · NCT07246408Cottonseed Oil Versus Matched PUFA Effects
- University of Georgia, Athens
RecruitingHealthy volunteers welcome
Ages 25 to 75 · All sexes · Updated Sep 9, 2026 · NCT06382298AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- NeuroTrials Research, Inc., Atlanta
- Physicians Research Associates, Lawrenceville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07571109A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- SKY Clinical Research Network Group-Brown, Atlanta
- Teak Research Consults, Lawrenceville
- AGILE Clinical Research Trials, LLC, Sandy Springs
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT07215559A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Southeast Research Specialists, Douglasville
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06857942A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Hope Clin Res & Wellness, Conyers
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07745504Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Center for Advanced Research and Education, Gainesville
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684235Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Decatur
- Kailera Clinical Site, Lilburn
- Kailera Clinical Site, Marietta
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284901Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Lilburn
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284875Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, Albany
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07284979A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
- CenExel Atlanta, Atlanta
- CenExel Decatur, Decatur
- CenExel Savannah, Savannah
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07724340A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Children's Healthcare Atlanta, Atlanta
- Columbus Research Foundation, Columbus
- Accel Research Sites-NeuroStudies, Decatur
- and 1 more
RecruitingPhase 3
Ages 8 to 18 · All sexes · Updated Aug 31, 2026 · NCT07253285Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Nsc Research, Johns Creek
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
- North Georgia Clinical Research, Woodstock
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Aug 27, 2026 · NCT07575399A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Stockbridge
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07784725Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Healthcare of Atlanta at Egleston, Atlanta
RecruitingPhase 2
Ages 7 to 25 · All sexes · Updated Aug 19, 2026 · NCT05082519A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- American Clinical Trials, LLC, Acworth
- Atlanta Center for Clinical Research_Atlanta, Atlanta
- East Atlanta Cardiology, Conyers
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
- NeuroTrials Research, Atlanta
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Aug 14, 2026 · NCT07226765From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.